✦ LIBER ✦

Fournier’s gangrene: analysis of prognostic variables in 34 patients

✍ Scribed by A. García Marín; J. Martín Gil; A. Vaquero Rodríguez; T. Sánchez Rodríguez; J. de Tomás Palacios; J. Lago Oliver; F. Turégano Fuentes

Publisher: Springer
Year: 2010
Tongue: English
Weight: 163 KB
Volume: 37
Category: Article
ISSN: 1439-0590
DOI: 10.1007/s00068-010-0028-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome Analysis in Patients With Fourni

Outcome Analysis in Patients With Fournier’s Gangrene

✍ Mustafa Korkut; Gökhan İçöz; Murat Dayangaç; Erhan Akgün; Levent Yeniay; Özgür E 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 120 KB

Fournier’s gangrene: an analysis of 80 p

Fournier’s gangrene: an analysis of 80 patients and a novel scoring system

✍ T. Yilmazlar; E. Ozturk; H. Ozguc; I. Ercan; H. Vuruskan; B. Oktay 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 198 KB

Hepatic Resection for Metastatic Breast

Hepatic Resection for Metastatic Breast Cancer: Prognostic Analysis of 34 Patients

✍ Yoshihiro Sakamoto; Junji Yamamoto; Masataka Yoshimoto; Fujio Kasumi; Tomoo Kosu 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 90 KB

Multivariate Analysis of Prognostic Fact

Multivariate Analysis of Prognostic Factors in Patients with Glioblastoma

✍ Johannes Lutterbach; Willi Sauerbrei; Roland Guttenberger 📂 Article 📅 2003 🏛 Springer 🌐 German ⚖ 139 KB

A principal component analysis of patien

A principal component analysis of patients, disease and treatment variables: a new prognostic tool in breast cancer after mastectomy

✍ Buciński Adam; Załuski Jerzy; Krysiński Jerzy; Kaliszan Roman 📂 Article 📅 2000 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 534 KB

Analysis of prognostic factors after the

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients

✍ Pauline Brice; Yves Bastion; Marine Divine; Gérard Nedellec; Augustin Ferrant; J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Patients in the first relapse of Hodgkin's disease comprise a heterogeneous group regarding their primary treatment and their clinical characteristics. Because therapeutic options for these patients vary from radiotherapy to combined modality or high dose therapy, we wanted to ident